Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-06-02
1994-03-01
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
424702, 514562, 514864, A61K 31355
Patent
active
052908097
ABSTRACT:
A pharmaceutical product to be used as an adjuvant treatment of seborrheic dermatitis even in HIV positive subjects is disclosed. The pharmaceutical product makes use of methionine, vitamin E and selenium as active principles which directly or indirectly provide a protective response to the damage caused by lipoperoxidation. The pharmaceutical product, in combination with a diet rich in PUFA-PL (polyunsaturated fatty acids of phospholipids), causes skin homeostasis to be restored and the symptoms of skin dermatitis to regress.
REFERENCES:
patent: 4613622 (1986-09-01), Moeller et al.
Brenner, S. and Horwitz, C., "Possible Nutrient Mediators in Psoriasis and Seborrheic Dermatitis", Wld Rev. Nutr. Diet., vol. 55, pp. 165-182, 1988.
Ippolito Ferdinando
Passi Siro
Istituto Fisioterapici Ospitalieri
Schenkman Leonard
LandOfFree
Methods for the treatment of seborrheic dermatitis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the treatment of seborrheic dermatitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the treatment of seborrheic dermatitis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-577519